Combination Therapies and Personalized Medicine
Targeted Cancer Therapies
Cancer Therapies
Cancer Survival Analysis
Treatment Resistant Cancers
Tumor Immunotherapy
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 7, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Jia Zeng1, Christian X Cruz-Pico2, Turçin Saridogan3
1Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
RetriLite, a novel framework, enhances discovery of anticancer combination therapies by using natural language processing. This tool aids researchers in identifying synergistic drug combinations for improved antitumor efficacy and overcoming resistance.
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: